Latest Insider Transactions at Ironwood Pharmaceuticals Inc (IRWD)
This section provides a real-time view of insider transactions for Ironwood Pharmaceuticals Inc (IRWD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IRONWOOD PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IRONWOOD PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Mark Mallon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,675
-3.1%
|
$276,075
$9.11 P/Share
|
|
Feb 26
2021
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,685
-1.01%
|
$132,165
$9.11 P/Share
|
|
Feb 26
2021
|
Edward P Owens Director |
BUY
Open market or private purchase
|
Direct |
3,000
+1.35%
|
$24,000
$8.9 P/Share
|
|
Feb 26
2021
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,651
-1.08%
|
$122,859
$9.11 P/Share
|
|
Feb 26
2021
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
4,439
-1.35%
|
$39,951
$9.11 P/Share
|
|
Feb 26
2021
|
Alexander J Denner |
BUY
Open market or private purchase
|
Indirect |
505,100
+3.36%
|
$4,545,900
$9.2 P/Share
|
|
Feb 25
2021
|
Edward P Owens Director |
BUY
Open market or private purchase
|
Direct |
5,000
+2.26%
|
$45,000
$9.11 P/Share
|
|
Feb 24
2021
|
Edward P Owens Director |
BUY
Open market or private purchase
|
Direct |
7,000
+3.21%
|
$63,000
$9.26 P/Share
|
|
Feb 22
2021
|
Gina Consylman SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
84,951
+19.32%
|
-
|
|
Feb 22
2021
|
Thomas A Mccourt Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
145,631
+23.05%
|
-
|
|
Feb 22
2021
|
Jason Rickard SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,951
+20.96%
|
-
|
|
Feb 22
2021
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
BUY
Grant, award, or other acquisition
|
Direct |
58,252
+26.06%
|
-
|
|
Dec 15
2020
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
661
+1.72%
|
-
|
|
Dec 15
2020
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
1,357
+1.18%
|
-
|
|
Dec 14
2020
|
Thomas A Mccourt Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
81,089
-19.23%
|
$973,068
$12.2 P/Share
|
|
Dec 14
2020
|
Thomas A Mccourt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
99,988
+19.17%
|
$899,892
$9.89 P/Share
|
|
Dec 04
2020
|
Kelly Mac Donald Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,639
-5.71%
|
$67,668
$12.5 P/Share
|
|
Dec 04
2020
|
Kelly Mac Donald Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,639
+5.41%
|
$50,751
$9.12 P/Share
|
|
Dec 03
2020
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
35,557
+36.67%
|
-
|
|
Nov 11
2020
|
Kelly Mac Donald Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,561
-3.69%
|
$39,171
$11.75 P/Share
|
|
Nov 11
2020
|
Kelly Mac Donald Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,561
+3.56%
|
$32,049
$9.31 P/Share
|
|
Nov 09
2020
|
Gina Consylman SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
1,415
-0.26%
|
$14,150
$10.92 P/Share
|
|
Nov 09
2020
|
Conor Kilroy SVP, GC & Secretary |
SELL
Open market or private sale
|
Direct |
836
-0.32%
|
$8,360
$10.92 P/Share
|
|
Nov 09
2020
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
394
-0.17%
|
$3,940
$10.92 P/Share
|
|
Nov 09
2020
|
Kelly Mac Donald Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
925
-0.49%
|
$9,250
$10.92 P/Share
|
|
Nov 09
2020
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
37,183
+45.07%
|
-
|
|
Nov 06
2020
|
Kelly Mac Donald Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,872
-1.95%
|
$20,592
$11.25 P/Share
|
|
Oct 08
2020
|
Kelly Mac Donald Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
22,714
-19.16%
|
$227,140
$10.5 P/Share
|